Preventing breakthrough pain after implant surgery: what to do on Monday morning

Use simple, evidence-based perioperative anti‑inflammatory strategies — preemptive or early NSAIDs, scheduled short-course dosing and selective use of single-dose steroids — to keep most patients comfortable and avoid unnecessary opioids.

Quick summary for the chair: recent clinical reviews and randomized trials reinforce a straightforward message — most pain after dental implant placement is inflammatory, usually mild-to-moderate, and can be prevented or blunted by nonopioid anti‑inflammatory strategies. A recent Compendium review emphasises starting NSAIDs early (ideally before anaesthesia wears off) and maintaining scheduled dosing for 48–72 hours to reduce the common problem of ‘‘breakthrough’’ pain seen with as‑needed dosing. ([eurekamag.com](

What the evidence says, in plain numbers: systematic reviews of implant analgesia find that giving perioperative analgesics reduces pain and the need for rescue medication compared with placebo; a 2021 systematic review of analgesics for dental implants pooled 11 trials (762 patients) and concluded analgesics improve postoperative outcomes though evidence about the single best drug was limited. ([pubmed.ncbi.nlm.nih.gov]( A meta-analysis focused on preemptive dosing showed a small but measurable reduction in pain early after surgery (first few hours). ([pubmed.ncbi.nlm.nih.gov](

Trials you can use in practice: a randomized trial of perioperative protocols for implant surgery enrolled 117 patients and compared preemptive ibuprofen (600 mg 1 hour before, then 600 mg 6 hours later), single‑dose dexamethasone (4 mg at the same schedule), and placebo. Both active approaches reduced postoperative pain and analgesic rescue use versus placebo in the early postoperative period. These are practical regimens you can adapt to your patients after screening for contraindications. ([aap.onlinelibrary.wiley.com](

How to translate this to a clinic with modest equipment: 1) Screen medical history at booking for NSAID contraindications (peptic ulcer, advanced CKD, uncontrolled hypertension, NSAID allergy, concurrent anticoagulants where your policy advises caution). If NSAIDs are unsuitable, acetaminophen is the preferred non‑NSAID option. 2) For routine single‑implant or straightforward flap procedures, either give a preemptive NSAID (example from trials: 600 mg ibuprofen 1 hour before surgery) or give the first NSAID dose immediately after surgery before the local anaesthetic wears off, and instruct scheduled dosing (eg, ibuprofen 400–600 mg every 6–8 hours as needed, but scheduled for 48–72 hours) rather than pure PRN. The recent ADA‑linked guideline recommends NSAIDs alone or combined with acetaminophen as first‑line for acute dental surgical pain. ([pmc.ncbi.nlm.nih.gov](

Consider a single perioperative steroid in selected patients. Short, single doses of dexamethasone (4 mg) reduced early pain and swelling in a randomized trial; this is useful when you expect swelling (longer flap, grafting) and in patients without diabetes or active infection. Use steroids selectively and counsel patients about blood‑sugar monitoring if diabetic. ([aap.onlinelibrary.wiley.com](

Reserve opioids as true rescue therapy in selected patients only. Evidence syntheses and professional consensus support nonopioid first‑line care; when opioids are used, prescribe the lowest effective quantity and give clear written instructions for use, storage and disposal. This reduces risk without sacrificing patient comfort. ([pmc.ncbi.nlm.nih.gov](

Practical checklist you can start using on Monday: a brief medical screen (NSAID risk, diabetes, ACE/anticoagulant meds), offer preemptive ibuprofen when safe (or plan immediate post‑op dosing), give a written 48–72‑hour analgesic plan (drug, dose, scheduled timing), offer acetaminophen backup and reserve a capped short opioid supply only for confirmed higher‑pain procedures. Document the counselling in the chart.

Limitations and caveats: studies vary in drugs, timing and doses; effect sizes are modest and mainly affect the first 6–8 postoperative hours. Patient factors (anxiety, surgical complexity, chronic pain conditions) alter needs — tailor plans rather than apply a single protocol to everyone. Also screen carefully for drug interactions and local prescribing rules.

Bottom line: you do not need fancy technology to prevent most post‑implant breakthrough pain. A simple, evidence‑based protocol centred on early/scheduled NSAIDs (or acetaminophen when NSAIDs are contraindicated), selective short steroid use, and conservative opioid prescribing will keep most patients comfortable and reduce phone calls the day after surgery.